Bethany Sensenig
CIK 1899935 · Chief Financial Officer · last filed 2026-06-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$32.9K
Companies
4
Total Filings
13
Lifetime Open-Market Net
-$466.1K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KALV | Director | — | $27.00 | — | $0 | 2 | 2026-06-11 |
| ACOG | Director | 5,489 | $5.99 | $32.9K | $0 | 1 | 2026-04-17 |
| SUPN | Director | 0 | $44.41 | $0 | -$455.1K | 7 | 2026-02-23 |
| 9 METERS BIOPHARMA, INC. (NMTR) Delisted | Chief Financial Officer | 41,077 | $0.07 | $3.0K | -$11.0K | 3 | 2023-04-21 |
Recent Filings · Page 2 of 2
13 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-04-21 | 9 METERS BIOPHARMA, INC. (NMTR) Delisted | Sell (S) | −9,100 | -$11.0K | EDGAR |
| 2023-03-29 | 9 METERS BIOPHARMA, INC. (NMTR) Delisted | Grant (A) | +50,177 | $0 | EDGAR |
| 2022-01-18 | 9 METERS BIOPHARMA, INC. (NMTR) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 11–13 of 13
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.